First National Bank of Hutchinson’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,086
| Closed | -$970K | – | 102 |
|
|
2024
Q3 | $970K | Sell |
2,086
-273
| -12% | -$127K | 0.63% | 39 |
|
|
2024
Q2 | $1.11M | Buy |
2,359
+48
| +2% | +$22.5K | 0.71% | 38 |
|
|
2024
Q1 | $966K | Buy |
2,311
+537
| +30% | +$224K | 0.65% | 38 |
|
|
2023
Q4 | $722K | Sell |
1,774
-16
| -0.9% | -$6.51K | 0.52% | 51 |
|
|
2023
Q3 | $622K | Buy |
1,790
+62
| +4% | +$21.6K | 0.47% | 56 |
|
|
2023
Q2 | $608K | Buy |
1,728
+8
| +0.5% | +$2.82K | 0.44% | 58 |
|
|
2023
Q1 | $542K | Buy |
1,720
+51
| +3% | +$16.1K | 0.43% | 65 |
|
|
2022
Q4 | $482K | Sell |
1,669
-4
| -0.2% | -$1.16K | 0.41% | 60 |
|
|
2022
Q3 | $484K | Buy |
1,673
+111
| +7% | +$32.1K | 0.39% | 52 |
|
|
2022
Q2 | $440K | Buy |
+1,562
| New | +$440K | 0.33% | 59 |
|